Philip Payne oversees Abzena’s global commercial and marketing strategies. Philip is responsible for driving new business creation, the cultivation of partner relationships, as well as identifying and supporting mergers and acquisition.
Philip joined Abzena in 2019 and has a long history working in the contract research and manufacturing industry initially in operations managing R&D and manufacturing teams. He combines his extensive leadership experience and deep technical knowledge of drug product development and manufacturing to ensure the global success of Abzena.
For over 25 years, he has worked in commercial teams helping partners to develop both small molecule and novel biologic therapies including the successful transition from clinical to commercial stages.
Prior to joining Abzena, Philip has held a variety of positions of increasing scope and responsibility including Chief commercial officer for Concept Life Sciences, Head of European and Middle East sales at Aptuit, Catalent, and RSSL.
Philip holds a BS.c. in Chemistry and Environmental Sciences from the University of Kent, UK.